Artificial Urinary Sphincter Market Size & Growth Forecast 2027–2036, By Segments (Brand, End-user), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Artificial Urinary Sphincter Market size was assessed at USD 643.4 million in 2026 and is poised to grow at a 6.75% CAGR between 2027 and 2036, exceeding USD 1.24 billion by 2036. The industry revenue for 2027 is estimated at USD 679.95 million.
Get more details on this report
Request Free Sample ReportArtificial Urinary Sphincter Market Intelligence Snapshot
Regional Market Dynamics
- North America holds largest share due to established urology pathways, experienced surgeons, and advanced hospital infrastructure enabling routine artificial urinary sphincter implantation for incontinence management.
- Asia Pacific is growing at 8.14% CAGR driven by improved access to urology services, expanding specialist availability, and gradual shift toward surgical continence treatments in urban hospitals.
Segment Momentum
- AMS 800 held an 80.99% market share in 2026, supported by strong clinical familiarity, long-term integration into treatment pathways, and physician confidence in its reliability and established surgical use.
- The female segment is growing fastest as clinicians increasingly evaluate artificial urinary sphincters for complex incontinence cases where conventional treatment options may not provide adequate long-term management.
Market Expansion Drivers
- Rising prevalence of prostate cancer, BPH, and spinal cord injuries driving demand.
- Expanding insurance reimbursement coverage supporting wider hospital adoption of AUS procedures.
- Adoption of smart automated sphincter devices improving post-surgical urinary incontinence management.
Leading Market Participants
- Key companies in the artificial urinary sphincter market include Boston Scientific Corporation (United States), Coloplast A/S (Denmark), Zephyr Surgical Implants (Switzerland), GT Urological (United States), UroMems SAS (France), Rigicon, Inc. (United States), Affluent Medical SA (France).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 643.4 million
- 2027 Estimated Market Size: USD 679.95 million.
- Projected Market Size: USD 1.24 billion by 2036
- Growth Forecast: 6.75% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: AMS 800 (Brand) | Male (End-user)
- Emerging Opportunity Segment: AMS 800 (Brand) | Female (End-user)
Market Growth Drivers and Industry Trends
Rising prevalence of prostate cancer, BPH, and spinal cord injuries driving demand
The increasing incidence of conditions associated with urinary sphincter dysfunction is creating a larger patient pool requiring effective continence management solutions. The artificial urinary sphincter market is supported by demand from patients experiencing stress urinary incontinence following prostate-related conditions, as well as those affected by benign prostatic hyperplasia, spinal cord injuries, and associated urological complications. As urinary control can significantly influence mobility, independence, and quality of life, patients and clinicians are increasingly considering implantable sphincter systems when conservative treatment options provide insufficient symptom control.
Expanding insurance reimbursement coverage supporting wider hospital adoption of AUS procedures
Improved reimbursement availability can reduce the financial barriers associated with artificial urinary sphincter implantation, supporting greater access to specialized urological procedures. Within the artificial urinary sphincter market, broader insurance coverage can encourage hospitals and physicians to offer AUS procedures to eligible patients by improving the affordability and financial feasibility of treatment. Reimbursement support also allows healthcare providers to incorporate advanced continence management into established urological care pathways, particularly where patients require long-term solutions for persistent stress urinary incontinence.
Adoption of smart automated sphincter devices improving post-surgical urinary incontinence management
Technological development in implantable continence devices is creating opportunities for more responsive and patient-oriented approaches to urinary incontinence management. The artificial urinary sphincter market can benefit from smart automated systems designed to improve control, usability, and monitoring following implantation. Greater automation may reduce the need for complex manual intervention while enabling device functionality to respond more effectively to patient requirements, supporting rehabilitation and day-to-day management for individuals experiencing persistent urinary incontinence after surgery or other underlying conditions.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of prostate cancer, BPH, and spinal cord injuries driving demand | 2.20% | High | North America, Europe | High | Near Term |
| Expanding insurance reimbursement coverage supporting wider hospital adoption of AUS procedures | 1.80% | High | North America, Europe | High | Mid Term |
| Adoption of smart automated sphincter devices improving post-surgical urinary incontinence management | 1.60% | High | North America, Asia Pacific | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
The artificial urinary sphincter market was led by North America, which held the largest share in 2026. The region benefits from advanced urological care infrastructure, broad access to specialized surgical expertise, and established treatment pathways for male urinary incontinence. Increasing awareness of surgical management options, particularly for patients experiencing persistent incontinence following prostate-related procedures, supports demand for artificial urinary sphincter systems. Continued improvements in implant design, surgical techniques, and postoperative management are also strengthening clinical acceptance. In addition, favorable access to specialized healthcare services and established reimbursement mechanisms support the adoption of advanced continence-restoration procedures.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region, supported by expanding urological healthcare infrastructure, rising healthcare expenditure, and improving access to specialized surgical procedures. Greater awareness of urinary incontinence and its treatment options is encouraging patients to seek definitive interventions rather than relying solely on conservative management. The increasing availability of trained urologists and modern hospital facilities is also improving access to implant-based therapies. Furthermore, the growing prevalence of prostate-related conditions, along with gradual improvements in healthcare coverage and medical technology adoption, is creating a stronger environment for the use of artificial urinary sphincters across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Clinical Quality FocusGermany prioritizes clinically validated artificial urinary sphincter solutions that align with established surgical pathways and hospital quality standards. German healthcare providers favor devices supported by long-term performance data and reliable postoperative patient outcomes.
France 🇫🇷
Specialist Care IntegrationFrance emphasizes coordinated urology care with careful patient selection and standardized surgical practices for artificial urinary sphincters. French healthcare providers prioritize technologies that fit established treatment pathways and improve quality-of-life outcomes.
Italy 🇮🇹
Reconstructive Urology SupportItaly encourages the use of artificial urinary sphincters within reconstructive urology programs addressing complex urinary incontinence cases. Italian hospitals focus on dependable implant performance and surgeon experience to optimize long-term patient satisfaction.
Japan 🇯🇵
Precision Surgical CareJapan focuses on minimally invasive implantation techniques and dependable device performance for patients with urinary incontinence. Japanese hospitals increasingly integrate advanced urological technologies that improve procedural consistency while supporting long-term patient management.
South Korea 🇰🇷
Innovation-Driven ProceduresSouth Korea promotes advanced urological interventions through modern surgical facilities and expanding specialist expertise. The country supports adoption of artificial urinary sphincters that complement precision treatment approaches and enhanced postoperative follow-up.
United States 🇺🇸
Advanced Urology AdoptionThe U.S. market emphasizes wider adoption of artificial urinary sphincters through specialized urology centers and continual product refinement. Growing attention to post-prostatectomy incontinence management encourages demand for durable devices supported by clinician training and patient awareness initiatives.
Segment Leadership and Growth Trends
Artificial Urinary Sphincter Market Share (%), by Brand, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportBrand Segment Analysis: AMS 800 (Largest & Fastest-Growing Segment)
The AMS 800 segment dominated the artificial urinary sphincter market, accounting for an 80.99% share in 2026, while also representing the fastest-growing brand segment. Its leading position reflects established clinical familiarity and broad recognition of the device within artificial urinary sphincter procedures. The segment benefits from accumulated physician experience, established surgical techniques, and familiarity with device operation and management among healthcare professionals. In addition, the continued need for effective management of severe urinary incontinence is supporting demand for established artificial urinary sphincter solutions. The combination of clinical familiarity, procedural experience, and continued demand for reliable continence restoration is helping sustain the segment's strong market position.
End-user Segment Analysis: Male (Largest Segment) vs Female (Fastest-Growing Segment)
In the artificial urinary sphincter market, the male segment held the largest position with an 83.18% share in 2026, reflecting the established use of artificial urinary sphincters for managing severe male urinary incontinence. Demand is supported by the occurrence of sphincter-related dysfunction following certain urological procedures and conditions, alongside continued physician familiarity with artificial urinary sphincter implantation in male patients. The established surgical pathway and long-standing clinical use of these devices contribute to the segment's dominant position.
The female segment is the fastest-growing end-user category as clinical interest in artificial urinary sphincter applications for women continues to expand. Increasing recognition of treatment options for severe female urinary incontinence, together with greater attention to individualized continence management, is creating opportunities for broader adoption. Advances in surgical approaches and growing clinical experience with female patients may further support utilization, particularly when conventional treatment options do not provide adequate outcomes. This expanding clinical consideration is strengthening the growth potential of the female segment.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Brand | AMS 800, Others | AMS 800 | AMS 800 |
| End-user | Male, Female | Male | Female |
Competitive Landscape and Market Positioning
Key companies in the artificial urinary sphincter market:
1. Boston Scientific Corporation (United States)
2. Coloplast A/S (Denmark)
3. Zephyr Surgical Implants (Switzerland)
4. GT Urological (United States)
5. UroMems SAS (France)
6. Rigicon Inc. (United States)
7. Affluent Medical SA (France)
The artificial urinary sphincter market is witnessing steady innovation as companies prioritize advanced implant technologies designed to improve comfort, reliability, and treatment outcomes. Increased investment in device miniaturization, durability enhancement, and surgical efficiency is strengthening product competitiveness within the market. Additionally, the growing need for effective urinary incontinence management solutions is encouraging the expansion of specialized treatment options and next-generation therapeutic systems.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Boston Scientific Corporation (United States) | |||||||
| Coloplast A/S (Denmark) | |||||||
| Zephyr Surgical Implants (Switzerland) | |||||||
| GT Urological (United States) | |||||||
| UroMems SAS (France) | |||||||
| Rigicon Inc. (United States) | |||||||
| Affluent Medical SA (France). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| UroMems | May-26 | UroMems secured US$60 million in strategic funding from Ajax Health Fund I. This investment is earmarked to support pivotal clinical trials for the UroActive System in the United States and France, while accelerating commercialization preparations for the smart automated artificial urinary sphincter technology designed to treat stress urinary incontinence. |
| UroMems | Nov-24 | UroMems appointed a former Axonics executive to its Board of Directors, strategically strengthening its leadership team with deep commercialization and operational expertise. This governance change aligns with the company's objective to transition its UroActive System, an automated artificial urinary sphincter, from clinical development toward large-scale market entry and commercial deployment. |
| AIIMS Bhubaneswar | Apr-24 | AIIMS Bhubaneswar expanded its urological care infrastructure by introducing specialized artificial urinary sphincter implantation services. This operational expansion increases access to clinical treatments for patients suffering from severe incontinence resulting from prostate surgeries, spinal cord injuries, and related pathologies, enhancing the institution's capacity to deliver advanced restorative care. |
| Amber Therapeutics | Mar-24 | Amber Therapeutics announced positive results from its first-in-human study of the Amber-UI, an implantable bioelectrical therapy device for urinary incontinence. The clinical data demonstrated favorable safety and performance profiles, establishing the platform as a significant technological development and a potential alternative treatment modality within the broader urinary incontinence clinical landscape. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Artificial Urinary Sphincter Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Incontinence Etiology | Post-Prostatectomy Incontinence, Neurological Incontinence, Post-Surgical Incontinence, Other Causes |
| Procedure Type | Primary Implantation, Revision Surgery, Explantation and Reimplantation |
| Healthcare Setting | Hospitals, Ambulatory Surgical Centers, Specialty Urology Clinics |
Artificial Urinary Sphincter Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Patient Eligibility and Treatment Gap Assessment |
|
| Next-Generation Continence Device Innovation Landscape |
|
| Market Entry Prioritization by Healthcare System Maturity |
|
Need a different cut of the data?
Request Custom ResearchHow large is the artificial urinary sphincter market?
How is the artificial urinary sphincter industry projected to perform over the next decade?
How is expanding reimbursement influencing adoption in the artificial urinary sphincter market?
Why are smart automated artificial urinary sphincters gaining clinical and purchasing interest?
Why does AMS 800 dominate the artificial urinary sphincter market?
What is driving growth in the female segment of the artificial urinary sphincter market?
Why does North America dominate the artificial urinary sphincter market?
How is Asia Pacific expanding in the artificial urinary sphincter market?
Who holds a significant market share in the artificial urinary sphincter landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization